• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Pneumococcal and influenza vaccine uptake in adults with inflammatory bowel disease in France: Results from a web-based study

tetano

Editor, Senior Moderator
Dig Liver Dis. 2018 Jan 2. pii: S1590-8658(17)31364-6. doi: 10.1016/j.dld.2017.12.027. [Epub ahead of print]
[h=1]Pneumococcal and influenza vaccine uptake in adults with inflammatory bowel disease in France: Results from a web-based study.[/h] Loubet P[SUP]1[/SUP], Verger P[SUP]2[/SUP], Abitbol V[SUP]3[/SUP], Peyrin-Biroulet L[SUP]4[/SUP], Launay O[SUP]5[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] Despite specific immunization guidelines for immunocompromised patients, there is a dearth of studies on inflammatory bowel disease (IBD) population in France.
[h=4]AIMS:[/h] To estimate the prevalence and predictors of influenza and pneumococcal vaccination rates in a sample of French IBD adults.
[h=4]METHODS:[/h] An anonymous online survey was submitted to members of several French immunocompromised patients' associations during the winter 2016.
[h=4]RESULTS:[/h] Overall, there were 199/1625 (12%) participants with an IBD. Among these, 32% were <30 years old, 85% were male, and 62% were treated with immunosuppressive therapy. Self-reported influenza vaccine uptake was 34% (95% CI [28-41]) and 38% (95% CI [31-44]) for pneumococcal vaccines. Healthcare provider's (HCP) recommendation for vaccination (adjusted OR 12.7 95% CI [5.6-28.8]), immunosuppressive therapy (aOR 2.3 [1.1-5.3]), better knowledge of vaccination (aOR 3.2 [1.1-9.2]) and favorable attitudes towards vaccination (aOR 3.4 [1.2-9.5]) were positively associated with influenza vaccine uptake. Vaccine recommendation by HCPs was the only independently associated factor with pneumococcal vaccines uptake (OR 187.7 [24.8-1422.5]).
[h=4]CONCLUSION:[/h] Immunization rates in our sample do not reach recommended levels. Factors associated with vaccination included high knowledge, favorable attitudes towards vaccination and recommendation for vaccination. This underlines the role of health care providers in contact with IBD patients.
Copyright ? 2018 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.


[h=4]KEYWORDS:[/h] Attitude; Immunization; Inflammatory bowel diseases; Influenza; Knowledge; Pneumococcal; Vaccination

PMID: 29371056 DOI: 10.1016/j.dld.2017.12.027
 
Back
Top Bottom